Trial Profile
US expanded access program of tenofovir disoproxil fumarate in the treatment of HIV-1 infected patients who have limited treatment options
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil fumarate (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 11 Oct 2005 New trial record.